abstract |
USE OF CALCIUM ANTAGONISTS OF FORMULA 1 WHEREIN THE SUBSTITUENTS HAVE VARIOUS SIGNIFICANCES IN THE TREATMENT OF CONDITIONS RELATED DIRECTLY OR INDIRECTLY TO IONIZED CALCIUM IN THE BLOOD AND COMBINATIONS OF CALCIUM ANTAGONISTS, E.G. OF FORMULA 1, WITH CALCITONINS. |